Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Nasdaq Delisting Determination - Appeal update

June 28, 2024
RNS Number : 2544U Renalytix PLC 28 June 2024   This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR").

Total Voting Rights

June 28, 2024
RNS Number : 2377U Renalytix PLC 28 June 2024     Renalytix plc ("Renalytix" or the "Company")   Total Voting Rights   LONDON  and  NEW YORK , 28 June 2024  -  Renalytix plc   (NASDAQ: RNLX) (LSE: RENX)   announces that at today's date, the Company's total issued share capital is   154,368,191

Form 8.3 - Renalytix Plc

June 27, 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.           KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

June 27, 2024
RNS Number : 1380U Stifel Nicolaus Europe Limited 27 June 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Form 8.3 - Renalytix Plc

June 26, 2024
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.           KEY INFORMATION (a) Full name of discloser: Pentwater Capital Management LP (b) Owner or controller of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

June 26, 2024
RNS Number : 9611T Stifel Nicolaus Europe Limited 26 June 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

June 25, 2024
RNS Number : 7650T Stifel Nicolaus Europe Limited 25 June 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of

Receipt of Nasdaq Delisting Determination - Appeal

June 25, 2024
RNS Number : 6814T Renalytix PLC 25 June 2024     This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR").

Change of public accounting firm

June 25, 2024
RNS Number : 6900T Renalytix PLC 25 June 2024       Renalytix plc ("Renalytix" or the "Company")   Change of public accounting firm   LONDON  and  NEW YORK , 25 June 2024  -  Renalytix plc  (NASDAQ: RNLX) (LSE: RENX)   announces the appointment of   CohnReznick LLP as the Company's US independent

Stifel Nicolaus Euro - Form 8.5 (EPT/RI) - Renalytix plc

June 24, 2024
RNS Number : 5724T Stifel Nicolaus Europe Limited 24 June 2024   FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Name of
Displaying 21 - 30 of 441